Support for a postresection prognostic score for pancreatic endocrine tumors

Michael G. Hurtuk, Anjali S. Godambe, Margo Shoup, Sherri Yong, Gerard V. Aranha

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: Prognostic scores predicting long-term survival of patients with pancreatic neuroendocrine tumors (PNETs) have been created. The purpose of this study was to validate a prognostic scoring scheme at a single institution. Methods: We reviewed all resections for PNETs from 1996 to 2004. Prognostic scores based on patient age, tumor grade, and distant metastasis were calculated. Survival was compared with an established postresection prognostic score for PNETs. Results: A total of 34 PNETs were identified. Predicted 5-year survival for prognostic scores of 1, 2, and 3 were 76.7%, 50.9%, and 35.7%, respectively. Final prognostic scores of 1, 2, and 3 were observed in 13 (38%), 18 (53%), and 3 (9%) patients, with observed actual 5-year survivals of 92.3%, 72.2%, and 66.7%, respectively. Conclusions: PNET prognostic scores were found to be inversely related to survival. PNET postresection prognostic score categories may be useful tools in predicting long-term survival.

Original languageEnglish (US)
Pages (from-to)406-410
Number of pages5
JournalAmerican journal of surgery
Volume201
Issue number3
DOIs
StatePublished - Mar 2011

Keywords

  • Pancreatic endocrine Tumor
  • Prognostic score

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Support for a postresection prognostic score for pancreatic endocrine tumors'. Together they form a unique fingerprint.

Cite this